Ratings Cornerstone FS plc

Equities

Market Closed - London S.E. Other stock markets 11:35:13 2024-05-10 am EDT			5-day change	1st Jan Change
35 ^GBX	-2.78%		-10.26%	+52.17%

May. 08	EARNINGS: International Biotechnology bullish; Andrews Sykes profit up	AN
Mar. 20	Cornerstone FS plans to change name to Finseta as part of growth plan	AN

The prospective high growth for the next fiscal years is among the main assets of the company
Over the last twelve months, the sales forecast has been frequently revised upwards.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
For several months, analysts have been revising their EPS estimates roughly upwards.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Over the past four months, analysts' average price target has been revised upwards significantly.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

The company has insufficient levels of profitability.
The valuation of the company is particularly high given the cash flows generated by its activity.

	1st Jan change	Capi.	ESG Refinitiv
CORNERSTONE FS PLC	+52.17%	25.15M	-
ORACLE CORPORATION	+10.66%	321B	B-
SAP SE	+26.23%	220B	B+
SERVICENOW, INC.	+3.30%	150B	B
CONSTELLATION SOFTWARE INC.	+13.73%	57.95B	D+
FAIR ISAAC CORPORATION	+14.14%	32.83B	C+
HUBSPOT, INC.	+3.00%	30.44B	B+
WISETECH GLOBAL LIMITED	+28.33%	21.13B	B-
MICROSTRATEGY INCORPORATED	+86.90%	20.94B	D+
SAGE GROUP PLC	+2.17%	14.97B	B-

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality